Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to improve the diagnostic of Lewy body dementia by combining the scintigraphy (SPECT) usig a spécific transporter and magnetic resonance imaging (MRI).


Clinical Trial Description

Lewy body dementia is the second leading cause of dementia in France after degenerative Alzheimer's disease.

However its dignosis is difficult. Its comes in large part from the similarity of symptoms with another close dementia syndrome : the Alzheimer disease . Therfore, its is very important to have a mean to distinguish between the two dementias.

One highlight of the Lewy body dementia process being dopaminergic degeneration, the use of specific radioactive tracers is thought to be the way. The radiotracer that has the greatest advantage for these explorations is currently the DaTSCAN because it binds specifically on the dopamine transporter and can be used in Single photon emission computed tomography (SPECT).

The aim of this study is to improve the performance of imaging in the diagnosis of dementia by combining scintigraphy (SPECT) and magnetic resonance imaging (MRI) in the exploration of the striatal region . The development of this method applied to a population of subjects, with hallucinations and cognitive disorders, should demonstrate the value and complementarity of metabolic images (SPECT) and morphological (MRI) within the differential diagnosis of Lewy body dementia and the Alzheimer disease .

From a methodological point of view, the patient will be included in hospital and will have a clinical diagnosis defined according to the criteria of dementia NINCDS-ADRDA for the Alzheimer disease and Mc-Keith criteria for Lewy body dementia. Their MMSE will be over 18 and they have in common recurrent visual hallucinations.

After the inclusion, two steps must be distinguished, a neuropsychological evaluation stage and an scitigraphy exploration . Before the SPECT , all patients should have an MRI. ;


Study Design

Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00820937
Study type Interventional
Source University Hospital, Limoges
Contact
Status Completed
Phase N/A
Start date March 2006
Completion date March 2008

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05499429 - Non-invasive Transcranial Focused Low-intensity Ultrasound Stimulation in Patients With Mild Lewy Body Dementia N/A
Withdrawn NCT05497817 - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia N/A
Recruiting NCT06337578 - Advances in Telephone-based Cognitive Screening Procedures
Terminated NCT02871427 - Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Phase 2
Completed NCT03305809 - A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) Phase 2
Completed NCT00209456 - Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia Phase 3
Recruiting NCT06263673 - Anti-Diabetic Medications to Fight PD and LBD Phase 4
Recruiting NCT06389032 - PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia N/A
Terminated NCT05778695 - Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones N/A
Active, not recruiting NCT05524181 - Telehealth-enabled Integrated Palliative Care for People With Dementia N/A
Completed NCT01339130 - Assessment of Social-emotional Functioning in Neurological Diseases N/A
Completed NCT04413851 - Feasibility of Passive Data Collection in Dementia Subjects With Agitation
Recruiting NCT03233646 - Retinal Imaging in Neurodegenerative Disease
Completed NCT02860338 - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE N/A
Recruiting NCT05779839 - A Study of Caregiver Connections Via Technology in Dementia N/A
Completed NCT03550131 - Innovations in Dementia Empowerment and Action N/A
Completed NCT02640729 - Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia Phase 2
Recruiting NCT03019757 - Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Recruiting NCT05826457 - North American Prodromal Synucleinopathy Consortium Stage 2
Recruiting NCT06005935 - Environmental and Reproductive Health Risk for Lewy Body Dementia